Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Peptides Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Brand
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Injectable Peptides Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injectable Peptides Market Perspective (2024-2034)
2.2 Injectable Peptides Growth Trends by Region
2.2.1 Global Injectable Peptides Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Injectable Peptides Historic Market Size by Region (2024-2024)
2.2.3 Injectable Peptides Forecasted Market Size by Region (2024-2034)
2.3 Injectable Peptides Market Dynamics
2.3.1 Injectable Peptides Industry Trends
2.3.2 Injectable Peptides Market Drivers
2.3.3 Injectable Peptides Market Challenges
2.3.4 Injectable Peptides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Peptides Players by Revenue
3.1.1 Global Top Injectable Peptides Players by Revenue (2024-2024)
3.1.2 Global Injectable Peptides Revenue Market Share by Players (2024-2024)
3.2 Global Injectable Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable Peptides Revenue
3.4 Global Injectable Peptides Market Concentration Ratio
3.4.1 Global Injectable Peptides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Peptides Revenue in 2022
3.5 Injectable Peptides Key Players Head office and Area Served
3.6 Key Players Injectable Peptides Product Solution and Service
3.7 Date of Enter into Injectable Peptides Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Peptides Breakdown Data by Type
4.1 Global Injectable Peptides Historic Market Size by Type (2024-2024)
4.2 Global Injectable Peptides Forecasted Market Size by Type (2024-2034)
5 Injectable Peptides Breakdown Data by Application
5.1 Global Injectable Peptides Historic Market Size by Application (2024-2024)
5.2 Global Injectable Peptides Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Injectable Peptides Market Size (2024-2034)
6.2 North America Injectable Peptides Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Injectable Peptides Market Size by Country (2024-2024)
6.4 North America Injectable Peptides Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Injectable Peptides Market Size (2024-2034)
7.2 Europe Injectable Peptides Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Injectable Peptides Market Size by Country (2024-2024)
7.4 Europe Injectable Peptides Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable Peptides Market Size (2024-2034)
8.2 Asia-Pacific Injectable Peptides Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Injectable Peptides Market Size by Region (2024-2024)
8.4 Asia-Pacific Injectable Peptides Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Injectable Peptides Market Size (2024-2034)
9.2 Latin America Injectable Peptides Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Injectable Peptides Market Size by Country (2024-2024)
9.4 Latin America Injectable Peptides Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Peptides Market Size (2024-2034)
10.2 Middle East & Africa Injectable Peptides Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Injectable Peptides Market Size by Country (2024-2024)
10.4 Middle East & Africa Injectable Peptides Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Injectable Peptides Introduction
11.1.4 Sanofi Revenue in Injectable Peptides Business (2024-2024)
11.1.5 Sanofi Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Injectable Peptides Introduction
11.2.4 Teva Revenue in Injectable Peptides Business (2024-2024)
11.2.5 Teva Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Injectable Peptides Introduction
11.3.4 Novo Nordisk Revenue in Injectable Peptides Business (2024-2024)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Injectable Peptides Introduction
11.4.4 Takeda Revenue in Injectable Peptides Business (2024-2024)
11.4.5 Takeda Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Injectable Peptides Introduction
11.5.4 Eli Lilly Revenue in Injectable Peptides Business (2024-2024)
11.5.5 Eli Lilly Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Injectable Peptides Introduction
11.6.4 AstraZeneca Revenue in Injectable Peptides Business (2024-2024)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Injectable Peptides Introduction
11.7.4 Novartis Revenue in Injectable Peptides Business (2024-2024)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Injectable Peptides Introduction
11.8.4 AbbVie Revenue in Injectable Peptides Business (2024-2024)
11.8.5 AbbVie Recent Development
11.9 Ipsen
11.9.1 Ipsen Company Detail
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Injectable Peptides Introduction
11.9.4 Ipsen Revenue in Injectable Peptides Business (2024-2024)
11.9.5 Ipsen Recent Development
11.10 Ferring
11.10.1 Ferring Company Detail
11.10.2 Ferring Business Overview
11.10.3 Ferring Injectable Peptides Introduction
11.10.4 Ferring Revenue in Injectable Peptides Business (2024-2024)
11.10.5 Ferring Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Injectable Peptides Introduction
11.11.4 Merck Revenue in Injectable Peptides Business (2024-2024)
11.11.5 Merck Recent Development
11.12 The Medicines
11.12.1 The Medicines Company Detail
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Injectable Peptides Introduction
11.12.4 The Medicines Revenue in Injectable Peptides Business (2024-2024)
11.12.5 The Medicines Recent Development
11.13 Roche
11.13.1 Roche Company Detail
11.13.2 Roche Business Overview
11.13.3 Roche Injectable Peptides Introduction
11.13.4 Roche Revenue in Injectable Peptides Business (2024-2024)
11.13.5 Roche Recent Development
11.14 J & J
11.14.1 J & J Company Detail
11.14.2 J & J Business Overview
11.14.3 J & J Injectable Peptides Introduction
11.14.4 J & J Revenue in Injectable Peptides Business (2024-2024)
11.14.5 J & J Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Injectable Peptides Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Brand
Table 3. Key Players of Generic Drug
Table 4. Global Injectable Peptides Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 5. Global Injectable Peptides Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Injectable Peptides Market Size by Region (2024-2024) & (US$ Million)
Table 7. Global Injectable Peptides Market Share by Region (2024-2024)
Table 8. Global Injectable Peptides Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Injectable Peptides Market Share by Region (2024-2034)
Table 10. Injectable Peptides Market Trends
Table 11. Injectable Peptides Market Drivers
Table 12. Injectable Peptides Market Challenges
Table 13. Injectable Peptides Market Restraints
Table 14. Global Injectable Peptides Revenue by Players (2024-2024) & (US$ Million)
Table 15. Global Injectable Peptides Market Share by Players (2024-2024)
Table 16. Global Top Injectable Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Peptides as of 2022)
Table 17. Ranking of Global Top Injectable Peptides Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Injectable Peptides Revenue (CR5 and HHI) & (2024-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Injectable Peptides Product Solution and Service
Table 21. Date of Enter into Injectable Peptides Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Injectable Peptides Market Size by Type (2024-2024) & (US$ Million)
Table 24. Global Injectable Peptides Revenue Market Share by Type (2024-2024)
Table 25. Global Injectable Peptides Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Injectable Peptides Revenue Market Share by Type (2024-2034)
Table 27. Global Injectable Peptides Market Size by Application (2024-2024) & (US$ Million)
Table 28. Global Injectable Peptides Revenue Market Share by Application (2024-2024)
Table 29. Global Injectable Peptides Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Injectable Peptides Revenue Market Share by Application (2024-2034)
Table 31. North America Injectable Peptides Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 32. North America Injectable Peptides Market Size by Country (2024-2024) & (US$ Million)
Table 33. North America Injectable Peptides Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Injectable Peptides Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 35. Europe Injectable Peptides Market Size by Country (2024-2024) & (US$ Million)
Table 36. Europe Injectable Peptides Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Injectable Peptides Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Asia-Pacific Injectable Peptides Market Size by Region (2024-2024) & (US$ Million)
Table 39. Asia-Pacific Injectable Peptides Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Injectable Peptides Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 41. Latin America Injectable Peptides Market Size by Country (2024-2024) & (US$ Million)
Table 42. Latin America Injectable Peptides Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Injectable Peptides Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 44. Middle East & Africa Injectable Peptides Market Size by Country (2024-2024) & (US$ Million)
Table 45. Middle East & Africa Injectable Peptides Market Size by Country (2024-2034) & (US$ Million)
Table 46. Sanofi Company Detail
Table 47. Sanofi Business Overview
Table 48. Sanofi Injectable Peptides Product
Table 49. Sanofi Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 50. Sanofi Recent Development
Table 51. Teva Company Detail
Table 52. Teva Business Overview
Table 53. Teva Injectable Peptides Product
Table 54. Teva Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 55. Teva Recent Development
Table 56. Novo Nordisk Company Detail
Table 57. Novo Nordisk Business Overview
Table 58. Novo Nordisk Injectable Peptides Product
Table 59. Novo Nordisk Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 60. Novo Nordisk Recent Development
Table 61. Takeda Company Detail
Table 62. Takeda Business Overview
Table 63. Takeda Injectable Peptides Product
Table 64. Takeda Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Eli Lilly Company Detail
Table 67. Eli Lilly Business Overview
Table 68. Eli Lilly Injectable Peptides Product
Table 69. Eli Lilly Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 70. Eli Lilly Recent Development
Table 71. AstraZeneca Company Detail
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Injectable Peptides Product
Table 74. AstraZeneca Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Novartis Company Detail
Table 77. Novartis Business Overview
Table 78. Novartis Injectable Peptides Product
Table 79. Novartis Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. AbbVie Company Detail
Table 82. AbbVie Business Overview
Table 83. AbbVie Injectable Peptides Product
Table 84. AbbVie Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 85. AbbVie Recent Development
Table 86. Ipsen Company Detail
Table 87. Ipsen Business Overview
Table 88. Ipsen Injectable Peptides Product
Table 89. Ipsen Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 90. Ipsen Recent Development
Table 91. Ferring Company Detail
Table 92. Ferring Business Overview
Table 93. Ferring Injectable Peptides Product
Table 94. Ferring Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 95. Ferring Recent Development
Table 96. Merck Company Detail
Table 97. Merck Business Overview
Table 98. Merck Injectable Peptides Product
Table 99. Merck Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 100. Merck Recent Development
Table 101. The Medicines Company Detail
Table 102. The Medicines Business Overview
Table 103. The Medicines Injectable Peptides Product
Table 104. The Medicines Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 105. The Medicines Recent Development
Table 106. Roche Company Detail
Table 107. Roche Business Overview
Table 108. Roche Injectable Peptides Product
Table 109. Roche Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 110. Roche Recent Development
Table 111. J & J Company Detail
Table 112. J & J Business Overview
Table 113. J & J Injectable Peptides Product
Table 114. J & J Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 115. J & J Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Peptides Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Injectable Peptides Market Share by Type: 2022 VS 2034
Figure 3. Brand Features
Figure 4. Generic Drug Features
Figure 5. Global Injectable Peptides Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Injectable Peptides Market Share by Application: 2022 VS 2034
Figure 7. Cancer Case Studies
Figure 8. Metabolic Disorders Case Studies
Figure 9. Central Nervous System Case Studies
Figure 10. Other Case Studies
Figure 11. Injectable Peptides Report Years Considered
Figure 12. Global Injectable Peptides Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 13. Global Injectable Peptides Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 14. Global Injectable Peptides Market Share by Region: 2022 VS 2034
Figure 15. Global Injectable Peptides Market Share by Players in 2022
Figure 16. Global Top Injectable Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Peptides as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Injectable Peptides Revenue in 2022
Figure 18. North America Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 19. North America Injectable Peptides Market Share by Country (2024-2034)
Figure 20. United States Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. Canada Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Europe Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Europe Injectable Peptides Market Share by Country (2024-2034)
Figure 24. Germany Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. France Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. U.K. Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. Italy Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Russia Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Nordic Countries Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Asia-Pacific Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Asia-Pacific Injectable Peptides Market Share by Region (2024-2034)
Figure 32. China Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Japan Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. South Korea Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. Southeast Asia Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. India Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Australia Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Latin America Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Latin America Injectable Peptides Market Share by Country (2024-2034)
Figure 40. Mexico Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Brazil Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Middle East & Africa Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Middle East & Africa Injectable Peptides Market Share by Country (2024-2034)
Figure 44. Turkey Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Saudi Arabia Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. Sanofi Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 47. Teva Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 48. Novo Nordisk Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 49. Takeda Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 50. Eli Lilly Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 51. AstraZeneca Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 52. Novartis Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 53. AbbVie Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 54. Ipsen Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 55. Ferring Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 56. Merck Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 57. The Medicines Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 58. Roche Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 59. J & J Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed